Humana Inc. (HUM): Price and Financial Metrics

Humana Inc. (HUM)

Today's Latest Price: $443.15 USD

5.92 (1.35%)

Updated Oct 22 2:31pm

Add HUM to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 9 in Medical - Health Insurance

See all "A" rated Strong Buy stocks

HUM Stock Summary

  • With a market capitalization of $57,842,278,632, Humana Inc has a greater market value than 96.61% of US stocks.
  • The capital turnover (annual revenue relative to shareholder's equity) for HUM is 4.89 -- better than 91.12% of US stocks.
  • Humana Inc's stock had its IPO on January 1, 1986, making it an older stock than 92.9% of US equities in our set.
  • Stocks that are quantitatively similar to HUM, based on their financial statements, market capitalization, and price volatility, are SHW, DG, PGR, ITW, and TJX.
  • Visit HUM's SEC page to see the company's official filings. To visit the company's web site, go to

HUM Stock Price Chart Interactive Chart >

Price chart for HUM

HUM Price/Volume Stats

Current price $443.15 52-week high $445.20
Prev. close $437.23 52-week low $208.25
Day low $434.72 Volume 194,287
Day high $443.70 Avg. volume 1,048,337
50-day MA $413.65 Dividend yield 0.57%
200-day MA $376.21 Market Cap 58.63B

Humana Inc. (HUM) Company Bio

Humana operates as a health and well-being company. The company operates through three segments: Retail, Group, and Healthcare Services. The company was founded in 1964 and is based in Louisville, Kentucky.

HUM Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$443.15$1583.01 263%

The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for Humana Inc. To summarize, we found that Humana Inc ranked in the 72th percentile in terms of potential gain offered. More precisely, our analysis suggests the stock is undervalued by approximately 264.5% on a DCF basis. In terms of the factors that were most noteworthy in this DCF analysis for HUM, they are:

  • The company's debt burden, as measured by earnings divided by interest payments, is 19.81 -- which is good for besting 85.78% of its peer stocks (US stocks in the Healthcare sector with positive cash flow).
  • HUM's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 2%; for context, that number is higher than 32.07% of tickers in our DCF set.

Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price

UHS, SKVI, CRHM, NVO, and ANTM can be thought of as valuation peers to HUM, in the sense that they are in the Healthcare sector and have a similar price forecast based on DCF valuation.

HUM Latest News Stream

Event/Time News Detail
Loading, please wait...

HUM Latest Social Stream

Loading social stream, please wait...

View Full HUM Social Stream

Latest HUM News From Around the Web

Below are the latest news stories about Humana Inc that investors may wish to consider to help them evaluate HUM as an investment opportunity.

Humana rolls out 2021 health plans in more counties nationwide

Humana (HUM) announces details of its 2021 Medicare product offerings, including Medicare Advantage and Prescription Drug Plans.Beneficiaries will also have new choices through the launch of 69 new MAPD plans across hundreds of additional counties. For 2021, Humana’s MA, including Honor plans, and MAPD plans are all recommended by USAA.Humana Honor,...

Seeking Alpha | October 1, 2020

Humana Rolls Out 2021 Medicare Advantage Health Plans with Expanded $0 Premiums and Enhanced Benefits in More Counties Nationwide

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana rolls out 2021 Medicare Advantage health plans with expanded $0 premiums and enhanced benefits in more counties nationwide.

Business Wire | October 1, 2020

University of Toledo Medical Center, University of Toledo Physicians Sign Network Agreements with Humana

TOLEDO, Ohio & LOUISVILLE, Ky.--(BUSINESS WIRE)--University of Toledo Medical Center, University of Toledo Physicians Sign Network Agreements with Humana

Business Wire | September 30, 2020

Rush Health and Humana Sign Medicare Network Agreement

CHICAGO & LOUISVILLE, Ky.--(BUSINESS WIRE)--Rush Health and Humana Sign Medicare Network Agreement

Business Wire | September 29, 2020

HUM Stock's Pretty Good Year Reflects a Surprising Side to the Health Crisis

Humana is making big profits because people are putting off procedures during the pandemic. Yet why is HUM stock undervalued.

InvestorPlace | September 24, 2020

Read More 'HUM' Stories Here

HUM Price Returns

1-mo 14.76%
3-mo 13.18%
6-mo 20.45%
1-year 53.75%
3-year 83.37%
5-year 171.89%
YTD 21.55%
2019 28.94%
2018 15.89%
2017 22.60%
2016 14.85%
2015 25.07%

HUM Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full HUM Dividend History

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.7621 seconds.